Important Alert

COVID-19 Updates

ASCRS OGS
Important Update

Important COVID-19 Update

Resources for Ophthalmologists: Important information and clinical guidance to help ophthalmologists navigate this shifting landscape including information on CMS providing financial relief for Medicare providers.
Menu
Home Clinical Education Cornea Long-Term Results of Crosslinking
Presentation
Long-Term Results of Crosslinking
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-302: Crosslinking Essentials: When to, How to, What to Expect, and What to Avoid
Presenter: Kenneth Beckman, MD
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

This presentation discusses several cases of keratoconus that had undergone corneal crosslinking. It discusses patient selection, long term results, and how to identify progression.
Filed Under
Cornea crosslinking keratoconus progression Kmax
View More Presentations from SYM-302

This presentation is from the session "SYM-302: Crosslinking Essentials: When to, How to, What to Expect, and What to Avoid" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.

View More From This Session
Browse All 2019 Annual Meeting Presentations On Demand

Related Content

Presentation
Epi on Vs. Epi Off
George O. Waring IV, MD, FACS 13:13 minutes
May 2019
Presentation
When Crosslinking Is Urgent
Kathryn M. Hatch, MD 09:36 minutes
May 2019
Poster
Variable Shape and Energy Delivered (ED), Topography-Customized (TG) CXL: 5-Year Efficacy and Stability
A. John Kanellopoulos, MD; Vasiliki Moustou ; Flavia Xhani
May 2019
Poster
Cross Linked Donor Corneas Resist Infections and Melts in Boston Type 1 Keratoprosthesis - a Case Series
Lional Raj Daniel Raj Ponniah, MD
May 2019
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2020 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.